Literature DB >> 3681197

Cystatin C, alias post-gamma-globulin: a marker for multiple sclerosis?

F Bollengier1.   

Abstract

Cystatin C, alias post-gamma-globulin or gamma-trace protein, has been shown to be a potent inhibitor of cysteine proteinases; this protein is normally present in different biological fluids, but particularly so in cerebrospinal fluid. The concentration of cystatin C was determined by radial immunodiffusion in cerebrospinal fluid from patients affected with multiple sclerosis, patients affected with various neurological diseases and in controls; it was also determined in brain tissue from 2 patients affected with multiple sclerosis and 3 control brains. Cystatin C cerebrospinal fluid levels were undetectable or depressed in many multiple sclerosis cases and the median value differed significantly from the control one. Its low concentration in multiple sclerosis suggests that the regulation of cysteine proteinases is impaired in this disease; hence enhanced activity of cysteine proteinases could initiate, or increase the breakdown of myelin. Although it is perhaps a little premature to consider cystatin C as a marker for multiple sclerosis, this protein is nevertheless associated to demyelination; consequently its biochemical assay in cerebrospinal fluid is recommended as a complementary diagnostic tool.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681197     DOI: 10.1515/cclm.1987.25.9.589

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  5 in total

Review 1.  Cystatin superfamily.

Authors:  Josiah Ochieng; Gautam Chaudhuri
Journal:  J Health Care Poor Underserved       Date:  2010-02

2.  Characterization of myelin-associated glycoprotein (MAG) proteolysis in the human central nervous system.

Authors:  J W Stebbins; H Jaffe; J R Möller
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

3.  Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells.

Authors:  Axel M Gressner; Birgit Lahme; Steffen K Meurer; Olav Gressner; Ralf Weiskirchen
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

Review 4.  Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions.

Authors:  Anas Shamsi; Bilqees Bano
Journal:  Int J Biol Macromol       Date:  2017-04-23       Impact factor: 6.953

5.  Cystatins in immune system.

Authors:  Spela Magister; Janko Kos
Journal:  J Cancer       Date:  2012-12-20       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.